GT Biopharma, Inc. (40)
Browse by Contract Category
Contracts
-
CONVERTIBLE NOTE DUE JANUARY 31, 2021
(Filed With SEC on December 28, 2020)
-
SETTLEMENTAGREEMENT
(Filed With SEC on December 28, 2020)
-
Board Service Agreement with Greg Berk, dated November 11, 2020
(Filed With SEC on November 13, 2020)
-
Employment agreement with Anthony Cataldo
(Filed With SEC on August 14, 2020)
-
AMENDMENT TO CONVERTIBLE NOTE & STANDSTILLAGREEMENT
(Filed With SEC on December 23, 2020)
-
Consultant Agreement with Michael Handelman, dated November 13, 2020
(Filed With SEC on November 13, 2020)
-
Board Service Agreement with Bruce Wendel, dated November 11, 2020
(Filed With SEC on November 13, 2020)
-
Steve Weldon Letter of Resignation, dated November 11, 2020
(Filed With SEC on November 13, 2020)
-
Form of Settlement Note, dated November 9, 2020
(Filed With SEC on November 13, 2020)
-
Settlement Agreement, dated as of November 9, 2020, by and among Adam Kasower, East Ventures, Inc., A British Virgin Islands company, SV Booth Investments III, LLC, a Delaware...
(Filed With SEC on November 13, 2020)
-
Securities Purchase Agreement
(Filed With SEC on November 9, 2020)
-
Form of Secured Convertible Note
(Filed With SEC on November 9, 2020)
-
Master Services Agreement
(Filed With SEC on October 6, 2020)
-
Securities Purchase Agreement
(Filed With SEC on September 22, 2020)
-
Form of Secured Convertible Note
(Filed With SEC on September 22, 2020)
-
Employment agreement with Steven Weldon
(Filed With SEC on August 14, 2020)
-
Form of Secured Convertible Note
(Filed With SEC on July 9, 2020)
-
Registration Rights Agreement
(Filed With SEC on July 9, 2020)
-
Securities Purchase Agreement
(Filed With SEC on July 9, 2020)
-
STANDSTILL AND FORBEARANCE AGREEMENT
(Filed With SEC on June 23, 2020)
-
Form of Pre-Funded Warrant to Purchase Common Stock, dated June 19, 2020 (included in Exhibit 10.1)
(Filed With SEC on June 19, 2020)
-
Settlement Agreement, dated as of June 19, 2020, among GT Biopharma, Inc., Empery Asset Master Ltd., Empery Tax Efficient, LP and Empery Tax Efficient II, LP, Anthony Cataldo and...
(Filed With SEC on June 19, 2020)
-
Form of Convertible Note, dated June 19, 2020 (included in Exhibit 10.1)
(Filed With SEC on June 19, 2020)
-
Clinical Trial Agreement with University of Minnesota
(Filed With SEC on May 15, 2020)
-
Form of Note, dated April/May, 2020
(Filed With SEC on May 15, 2020)
-
Form of Registration Rights Agreement by and among the Company and the Buyers, dated April/May, 2020
(Filed With SEC on May 15, 2020)
-
Securities Purchase Agreement by and among the Company and the Buyers, dated April/May, 2020
(Filed With SEC on May 15, 2020)
-
Form of Note, dated January 30, 2020
(Filed With SEC on May 15, 2020)
-
Form of Registration Rights Agreement by and among the Company and the Buyers, dated January 30, 2020
(Filed With SEC on May 15, 2020)
-
Securities Purchase Agreement by and among the Company and the Buyers, dated January 30, 2020
(Filed With SEC on May 15, 2020)
-
Form of Secured Convertible Note
(Filed With SEC on August 23, 2019)
-
Registration Rights Agreement
(Filed With SEC on August 23, 2019)
-
Securities Purchase Agreement
(Filed With SEC on August 23, 2019)
-
REGISTRATION RIGHTS AGREEMENT
(Filed With SEC on May 24, 2019)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on May 24, 2019)
-
CONVERTIBLE NOTE DUE NOVEMBER ___, 2019
(Filed With SEC on May 24, 2019)
-
Securities Purchase Agreement by and among the Company and the Purchasers, dated February 4, 2019
(Filed With SEC on February 6, 2019)
-
Registration Rights Agreement by and among the Company and the Purchasers, dated February 4, 2019
(Filed With SEC on February 6, 2019)
-
Security Agreement by and among the Company, Alpha Capital Anstalt, as collateral agent, and the Purchasers, dated February 4, 2019
(Filed With SEC on February 6, 2019)
-
Form of Secured Convertible Note, dated February 4, 2019
(Filed With SEC on February 6, 2019)
